BioHackers Choice
HomeDisclaimerSign in
← Back to compounds
Image coming soon

— peptide / recovery —

Pentadeca Arginate (PDA) 5mg· 5mg

Arginate salt form of a BPC-related pentadecapeptide investigated in early research contexts for tissue repair and stability characteristics.

Newer formulation refinement of BPC-157 with enhanced stability characteristics. Same active sequence as BPC-157. Read more →

From Retail $23 USDT

Member $20.00 USDT

Members save 15% — free to join

⏱Sold Out — Longer wait

Order now to reserve — we'll ship as soon as inventory is replenished.

Research-grade material. Documentation summarizes published literature in third-person scientific context. Not medical advice; not for human consumption.

— Pricing —

Three ways to source this compound.

All prices in USDT. Crypto pays settle directly to our wallet.

Single vial

Retail $23 USDT

Member $20.00 USDT

Members save 15% — free to join

1 vial · $20.00 USDT per vial

Most flexible

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

5-Pack

Save 13%

Retail $100 USDT

Member $87.00 USDT

Members save 15% — free to join

5 vials · $17.40 USDT per vial

Researcher's choice

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

10-Pack

Best value

Retail $145 USDT

Member $126.00 USDT

Members save 15% — free to join

10 vials · $12.60 USDT per vial

Pre-order reserves your spot in the restock queue.

USDT settlement · 3% off if you pay in crypto.

— The literature —

From the research record.

The pentadecapeptide sequence shared between PDA and BPC-157 has been reported in preclinical literature to engage multiple molecular pathways relevant to tissue repair. Upregulation of VEGFR2 expression and signaling has been observed in endothelial preparations, with corresponding increases in capillary tube formation in Matrigel assays and accelerated revascularization in rodent injury models.

Activation of the nitric oxide system, including modulation of endothelial nitric oxide synthase activity, has been documented in cardiovascular and gastrointestinal models. The peptide has been reported to engage the brain-gut axis through effects on dopaminergic, serotonergic, and GABAergic neurotransmission, observations that derive from rodent behavioral and neurochemical studies. Additional reports describe effects on growth hormone receptor expression in tendon fibroblasts and on transcription factor early growth response 1 (EGR-1) in tendon healing preparations. The arginate counterion is proposed to affect dissolution and stability rather than receptor-level pharmacology.

All compounds discussed are intended for research use only. Not for human consumption. Research-context information is educational and does not constitute medical advice.

View the full disclaimer →